Formulary Search

This product has not been assessed for inclusion on the formulary. Contact your pharmacy team for advice on making an applicationto the APC.

Rapid eye movement  sleep behaviour disorder. (RBD)

On specialist recommendation

Melatonin 2mg MR tablets are the recommended preferred 1st line product

Prescribe generically.  Circadin is NON-FORMULARY

Rapid eye movement  sleep behaviour disorder. (RBD)

If immediate onset of action is required or crushed to aid swallowing

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

Reserved ONLY if feeding tube in situ, or significant swallowing difficulties, and the use of the whole or crushed tablets are unsuitable

On specialist recommendation

Rapid eye movement  sleep behaviour disorder. (RBD)

Initiaition and a minimum of 1 month supply by the specialis team before any request is made for transfer of prescribing responsibility.

Safinamide has been agreed for use as a last line oral treatment option for its licensed indication in PD patients who:

• are contraindicated to, have failed or cannot tolerate rasagiline or selegiline (after an adequate trial), OR
• are considered for advanced, non-oral treatments e.g. deep brain stimulation, apomorphine and levodopa/carbidopa intestinal gel (LCIG).

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Sublingual apomorphine has not yet been assessed for inclusion on the joint formulary.

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Will need tertiary centre approval before Blueteq/funding released

This drug / device has not been assessed for inclusion on the formulary. Contact Pharmacy for advice.